Aspartate aminotransferase to alanine aminotransferase ratio is associated with frailty and mortality in older patients with heart failure
نویسندگان
چکیده
Abstract Frailty is a common comorbidity associated with adverse events in patients heart failure, and early recognition key to improving its management. We hypothesized that the AST ALT ratio (AAR) could be marker of frailty failure. Data from FRAGILE-HF study were analyzed. A total 1327 aged ? 65 years hospitalized failure categorized into three groups based on their AAR at discharge: low (AAR < 1.16, n = 434); middle (1.16 ? 1.70, 487); high 406). The primary endpoint was one-year mortality. association between physical function also assessed. High lower short performance battery shorter 6-min walk distance, these associations independent age sex. Logistic regression analysis revealed an after adjustment for age, sex body mass index. During follow-up, all-cause death occurred 161 patients. After adjusting confounding factors, (low vs. AAR, hazard ratio: 1.57, 95% confidence interval, 1.02–2.42; P 0.040). In conclusion, prognostic mortality older
منابع مشابه
The aspartate aminotransferase-to-alanine aminotransferase ratio predicts all-cause and cardiovascular mortality in patients with type 2 diabetes
An increased aspartate aminotransferase-to-alanine aminotransferase ratio (AAR) has been widely used as a marker of advanced hepatic fibrosis. Increased AAR was also shown to be significantly associated with the risk of developing cardiovascular (CV) disease. The aim of this study was to assess the relationship between the AAR and mortality risk in a well-characterized cohort of patients with t...
متن کاملUnusually high alanine aminotransferase to aspartate aminotransferase ratio in a patient with cyproterone-induced icteric hepatitis.
A 70-year-old man with prostatic adenocarcinoma received cyproterone acetate 200 mg per day. Three months later, mild fatigue and anorexia with elevation of the alanine aminotransferase (ALT) level to 1311 U/L, total bilirubin level to 14 mg/dL and prothrombin time of 15/11.9 seconds developed. At that time the aspartate aminotransferase (AST) level was only 82 U/L. Viral hepatitis and autoimmu...
متن کاملCorrelation of serum alanine aminotransferase and aspartate aminotransferase with coronary heart disease.
OBJECTIVE This study aimed to explore the relationship between different risk factors (especially serum alanine aminotransferase [ALT] and aspartate aminotransferase [AST]) and coronary heart disease (CHD). METHODS A total of 610 inpatients were recruited. Initial coronary angiography (CAG) was performed to evaluate the severity of coronary lesions. On the basis of findings from CAG, patients...
متن کاملOptimization of methods for aspartate aminotransferase and alanine aminotransferase.
Conditions for accurate measurement of catalytic activity of aspartate aminotransferase and alanine aminotransferase in human serum have been reinvestigated. The basic variables (kind of buffer, buffer concentration, pH, ion effects, and the influence of pyridoxal-5-phosphate) can now be considered optimized. On this basis, the kinetic parameters of both aminotransferases were determined, i.e.,...
متن کاملAlanine aminotransferase/aspartate aminotransferase ratio reversal and prolonged prothrombin time: a specific indicator of hepatic cirrhosis.
BACKGROUND Both ALT/AST ratio reversal (AST/ALT > 1) and prolonged prothrombin time are separately related to hepatic cirrhosis. Ratio reversal means that in normal individuals ALT is more than AST and thus ALT/AST > 1 but with development of cirrhosis AST becomes > ALT and so AST/ALT > 1 or ALT/AST < 1. This study was conducted with the idea that prolonged prothrombin time and reversed (AST/AL...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Scientific Reports
سال: 2021
ISSN: ['2045-2322']
DOI: https://doi.org/10.1038/s41598-021-91368-z